News

Athira Pharma's Path to Compliance Amid Trading Challenges

Athira Pharma's Path to Compliance Amid Trading Challenges

Athira Pharma's Recent Nasdaq Notification

Athira Pharma, Inc., based in Bothell, WA, has recently received important news regarding its listing status on The Nasdaq Global Select Market. The biotech company has been notified that it is currently not meeting the required minimum bid price for its common stock. Specifically, Athira's shares have closed below the minimum threshold of $1.00 for 30 consecutive business days, prompting this notification.

Despite the notification, there is no immediate impact on the trading of Athira's stock, which continues to be traded under the ticker symbol NASDAQ:ATHA. The company has until April 14, 2025, to regain compliance with the $1.00 minimum bid requirement, needing to maintain this share price for at least 10 consecutive business days.

Potential Paths to Compliance

If Athira Pharma does not meet the bid price requirement by the specified deadline, it might have an additional opportunity for compliance. The company could apply for an extension of 180 days by transferring to the Nasdaq Capital Market, contingent upon meeting specific conditions. This might include the prospect of a reverse stock split if necessary.

Strategic Moves Amidst Challenges

On a proactive front, Athira Pharma has revealed plans to file a new registration statement on Form S-3 with the Securities and Exchange Commission (SEC). This filing comes in anticipation of the expiration of its current shelf registration, which is set to lapse on November 24, 2024. The new statement aims to facilitate offering and selling securities worth up to $300 million, representing the unsold portion from the previous registration.

In light of recent events, including unfavorable results from its Phase 2/3 LIFT-AD study for the Alzheimer's drug fosgonimeton, Athira Pharma has also shifted its focus. This trial, unfortunately, did not meet its expected efficacy endpoints, leading to the discontinuation of the fosgo program. Following these developments, Mizuho Securities downgraded the company’s stock rating to 'Neutral' while also slashing its price target significantly.

New Focus on ALS Treatment

Athira Pharma's strategic pivot now centers on ATH-1105, a promising drug currently undergoing Phase 1 trials for treating amyotrophic lateral sclerosis (ALS). In conjunction with this strategic change, the company announced a significant workforce reduction of 70%, highlighting the gravity of its situation. Despite these challenges, analysts from Mizuho have maintained an Outperform rating, while BTIG downgraded its stock from Buy to Neutral, reflecting concerns over the drug’s developmental pathway.

Corporate Governance and Legal Developments

Amid these challenges, Athira has reached a preliminary settlement regarding a shareholder derivative lawsuit. This settlement includes implementing corporate governance reforms and covering legal fees. These actions reflect Athira Pharma's commitment to advancing its pipeline of therapeutics despite setbacks. The company is now anticipating the release of the first top-line efficacy data for ATH-1105 in ALS, which is expected in 2026.

Financial Insights from Recent Data

Recent insights into Athira Pharma’s financial health shed light on the challenges it faces regarding Nasdaq compliance. With a market capitalization of only $18.07 million, this indicates the company’s current struggles in the market. Moreover, a price-to-book ratio of 0.22 suggests that Athira's stock is trading below its intrinsic book value, presenting opportunities for potential value investors who might be willing to take risks during such uncertain times.

Furthermore, analysts highlight that Athira holds more cash than it does debt, which positions the company to maintain some financial flexibility as it navigates through its current listing challenges. However, there is concern as the company is reportedly 'quickly burning through cash,' adding pressure to find solutions swiftly.

In terms of stock performance, the recent statistics indicate a steep decline of 86.05% over the last three months. This dramatic dip coincides with the Nasdaq notification, showcasing the difficulties Athira is navigating. Additionally, certain financial metrics suggest that the stock may be traded in oversold territory, which could draw interest from contrarian investors willing to seek value in downtrends.

Conclusion

In summary, Athira Pharma is at a critical juncture as it grapples with Nasdaq delisting threats, wavering stock performance, and strategic pivots in its drug development pipeline. The upcoming milestones, bolstered by a renewed focus and strategic changes, present both challenges and opportunities for the company moving forward.

Frequently Asked Questions

What triggered the Nasdaq notification for Athira Pharma?

The notification was triggered because Athira Pharma's stock has closed below the minimum bid price of $1.00 for 30 consecutive business days.

How does Athira Pharma plan to regain compliance with Nasdaq?

Athira Pharma must ensure its stock closes at or above $1.00 for at least 10 consecutive business days to regain compliance.

What is the significance of the new registration statement Athira plans to file?

The new registration statement will allow Athira Pharma to offer and sell securities worth up to $300 million, enabling funding for its projects.

What drug is Athira Pharma focusing on after the fosgonimeton trial?

Athira Pharma is now focusing on ATH-1105, which is currently in Phase 1 trials for treating ALS.

What financial indicators reflect Athira's current situation?

Athira's market capitalization is $18.07 million, with a price-to-book ratio of 0.22, indicating its stock is trading below book value.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Frost & Sullivan’s 65 Years Put APAC Growth on Display

Updated Category News Views 95

A Crowded Singapore Room Says Something Singapore did not host a mere anniversary toast on November 18; it hosted a pretty revealing cross-section of the businesses trying to build, secure, cool, connect, finance, and digitize Asia Pacific and MEASA. Frost & Sullivan marked 65 years with its 2026 Best Practices Recognition banquet at Hilton Singapore Orchard, gathering...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 45

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Childcare Scale Makes Its Case, With Caveats Attached

Updated Category News Views 23

Childcare’s math is brutal before anybody starts arguing over ownership. Families need dependable hours, educators deserve better pay, and operators must keep buildings safe, staffed and open without pricing working parents clean out of the market. That is why this new Tyton Partners review of multi-site providers deserves a fair look, even if nobody should mistake a...

Continue Reading
Art Limitless Jury Puts SDG 12 and Art Into Clear Focus

Updated Category News Views 56

A paint pigment, a discarded object, and a serious climate question have landed in the same room. BE OPEN Art’s 2026 Art Limitless competition is aimed at SDG 12, the United Nations goal centered on responsible production and consumption. That may sound like institutional language built for conference folders, but the underlying issue is plain enough: society cannot...

Continue Reading
Prospera’s DFW Culture Win Matters Beyond the Plaque

Updated Category News Views 46

Employee survey ballots rarely make pulses race, but this one deserves more than a lazy shrug. Prospera Financial Services has landed on The Dallas Morning News’ 2026 Top Workplaces DFW list for a second consecutive year, placing in the Top Small Workplaces category. For a boutique independent broker-dealer, that is not meaningless wall décor. The people doing the...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 33

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
PAG, HOWL and PSNL Deals Face Fresh Shareholder Checks

Updated Category News Views 60

Three proposed takeovers, three very different headaches, and one familiar question that never gets old: are regular shareholders actually receiving the best available deal? On Nov. 20, 2026, investor-rights law firm Halper Sadeh LLC said it was investigating the proposed transactions involving Penske Automotive Group, Werewolf Therapeutics and Personalis for potential...

Continue Reading
Why Brief Chiropractic Visits Still Need Clear Expectations

Updated Category News Views 76

A few minutes on the table can sound almost suspiciously brisk when somebody is dealing with a stiff neck, sore back, or nagging joint discomfort. Yet that is the central point in Dr. Craig Peterson's explanation for HelloNation: the adjustment itself may be brief, while the value of a chiropractor visit depends on a focused assessment, appropriate technique, and whether...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 82

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
Re-Decking or Rebuilding Starts Below the Deck Boards

Updated Category News Views 37

A weathered deck can fool the eye in both directions: ugly boards may sit atop solid framing, while a tidy surface can hide trouble where nobody bothers to look. That is the useful, sober point in Dawn Walsh's guidance for Knoxville homeowners. The decision is not really about whether the top boards look tired. It is about whether the bones underneath still deserve...

Continue Reading

Top 5 Most Recently Viewed Articles

Rocky Mountain Chocolate Factory's Strategic Growth Plans Unfold

Updated Category News Views 370

Rocky Mountain Chocolate Factory Reports Q2 Loss and Future Plans Rocky Mountain Chocolate Factory (RMCF) has recently revealed a net loss of $0.7 million in its Fiscal Q2 2025, showcasing some improvement from the previous year's loss of $1 million. Despite this setback, the company reported a slight decrease in total revenue from $6.6 million to $6.4 million, indicating...

Continue Reading
Bird Canada's Exciting E-Scooter and E-Bike Launch in Halifax

Updated Category News Views 358

Bird Canada Expands Its Eco-Friendly Services In an exciting development for Halifax, Bird Canada, the nation’s leading micromobility provider, has launched an impressive fleet of 300 e-scooters and 300 e-bikes. Thanks to a partnership with the Halifax Regional Municipality, residents and visitors now have an innovative and enjoyable way to navigate through the city....

Continue Reading
Surprising Trends in Brand Value: Insights from Interbrand

Updated Category News Views 186

Understanding the Value of Global Brands For over two decades, the landscape of brand valuation has shown significant shifts, exposing missed opportunities and unrealized potential. Interbrand's latest report reveals that the world's 100 most valuable brands have collectively overlooked an astonishing $3.5 trillion in potential value creation since the turn of the...

Continue Reading
Exploring Therabody's New Wellness Offerings at Ulta Beauty

Updated Category News Views 384

Introducing Therabody at Ulta Beauty Science-backed wellness encompasses more than just traditional beauty routines; it includes a holistic approach to self-care. With this belief, Therabody has taken an exciting step by launching its innovative wellness tools at Ulta Beauty, a leader in the beauty retail space. Beginning this Fall, shoppers can explore a curated...

Continue Reading
Matador Technologies Inc.'s Bold Step to Expand Its Bitcoin Holdings

Updated Category News Views 207

Matador Technologies Inc. Secures Financing for Bitcoin Expansion Matador Technologies Inc. has recently announced a remarkable step in its journey to further integrate Bitcoin into its treasury strategy. The company has executed a Purchase Agreement for a secured convertible note facility worth USD $100 million, working with ATW Partners, which kicks off with an initial...

Continue Reading